Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 23 (RPL29P23)

Target
RPL29P23
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L29 pseudogene 23 (RPL29P23) is a processed pseudogene in the human genome derived from the functional RPL29 gene. Like most ribosomal protein pseudogenes, it does not generate a functional protein product and has no established biological or disease-associated roles. There is no evidence implicating it as a therapeutic or diagnostic target. Its presence reflects the widespread pseudogenization of ribosomal protein genes in mammalian genomes[4][5][7]. Note: Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they often result from gene duplication or retrotransposition events and generally do not produce functional proteins or RNAs. RPL29P23 is not listed in resources as having any known biological activity or clinical relevance[4][5].

Other names
RPL29_11_1134

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 23 (RPL29P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 23 (RPL29P23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call